Permanent link of this page:

Current Editions


Vigilance-News Edition 28

In this edition:

COVID-19 immunisation:

  • Modification of the Information for healthcare professionals since authorisation
  • Myocarditis, thromboembolic events, multiple sclerosis
  • Persistent headache
  • Methods of signal detection / ”Observed versus expected” analyses


Vigilance-News Edition 27

In this edition:

COVID-19 immunisation:

  • Myocarditis/pericarditis: Case reports received by Swissmedic
  • Menstrual disorders – facts, possible causes, unanswered questions
  • Recent study findings and recommendations
    for vaccination of pregnant women
  • International cooperation
    in the area of pharmacovigilance


Vigilance-News Edition 26

In this edition:

  • COVID-19 vaccines: reporting suspected side effects correctly
  • Case report “COVID arm”
  • AEFI after immunisation with COVID-19 vaccines: Herpes zoster, neuralgic amyotrophy, immune thrombocytopenia


Vigilance-News Edition 25

In this edition:

  • New reporting routes for adverse drug reaction reports
  • CRS associated with immune checkpoint inhibitors
  • Intravenous iron and osteomalacia
  • Signal management


Vigilance-News Edition 24

Keywords in this edition: Guest article: valproate during pregnancy, Asthma triggered by Aspirin?, Nitro-resistant, triptan-induced acute coronary syndrome, ICH E2D Guideline revision


Vigilance-News Edition 23

Keywords in this edition:
Oral anticoagulants under real-world conditions, ADR in the elderly, Haemophagocytic lymphohistiocytosis, Case report, Statistical Review 2018


Vigilance News Edition 22

Keywords in this edition: Current case report, WHO - Annual pharmacovigilance meeting, Medicinal product risks, Information for patients, Collaboration on the safety of medicines


Vigilance News Edition 21

Keywords in this edition: Isotretinoin, DOAC, confusions amphotericin B formulations, guest articles RPVC, transfusion practice, statistical review 2017


Vigilance News Edition 20

Special issue: The history and development of pharmacovigilance in Switzerland over the last three decades

Previous issues